Muscle-derived follistatin-like 1 functions to reduce neointimal formation after vascular injury - Wikidata - awgldk - TriplyDB

Muscle-derived follistatin-like 1 functions to reduce neointimal formation after vascular injury

Muscle-derived follistatin-like 1 functions to reduce neointimal formation after vascular injury

http://www.wikidata.org/entity/Q28238431

about

Vasculoprotective Effects of 3-Hydroxybenzaldehyde against VSMCs Proliferation and ECs Inflammation Dissecting the role of AMP-activated protein kinase in human diseases.Association of Circulating Follistatin-Like 1 Levels with Inflammatory and Oxidative Stress Markers in Healthy Men The expression and post-transcriptional regulation of FSTL1 transcripts in placental trophoblasts.Growth hormone replacement therapy regulates microRNA-29a and targets involved in insulin resistance Follistatin like 1 Regulates Hypertrophy in Heart Failure with Preserved Ejection Fraction Follistatin-like 1 promotes cardiac fibroblast activation and protects the heart from rupture.FSTL1 as a Potential Mediator of Exercise-Induced Cardioprotection in Post-Myocardial Infarction Rats.Assessed and Emerging Biomarkers in Stroke and Training-Mediated Stroke Recovery: State of the Art.Follistatin-like 1 protects against hypoxia-induced pulmonary hypertension in mice.The Role of Adipocytokines in Coronary Atherosclerosis.Common Variants of Vitamin D Receptor Gene Polymorphisms and Susceptibility to Coronary Artery Disease: A Systematic Review and Meta-Analysis.Muscle as a paracrine and endocrine organ.Acute and Chronic Increases of Circulating FSTL1 Normalize Energy Substrate Metabolism in Pacing-Induced Heart Failure.Unravelling the effects of mechanical physiological conditioning on cardiac adipose tissue-derived progenitor cells in vitro and in silico.Skeletal Muscle as an Endocrine Organ: The Role of Myokines in Exercise Adaptations.Follistatin-like 1 in development and human diseases.Deficiency of Follistatin-Like Protein 1 Accelerates the Growth of Breast Cancer Cells at Lung Metastatic Sites

P2860

Q28550935-0B66BC10-BCF4-4012-AB30-FFC45E3FF326 Q33682914-10C338BC-8499-4209-A1B6-F2B42EF99B5A Q36008387-AAEF7AE6-A729-477B-881C-262105405B44 Q36278850-DF2F93D9-6BE8-4E5B-A8B6-9133B76BDBA8 Q36322951-FA84A9B5-9F6E-4A8E-8ABC-D557D6770BE5 Q37094365-BE27753C-8EEA-4388-92FD-283B0109B28A Q37141388-FE30841B-7C57-4EAC-B7A5-84997528FAFE Q37209367-4ACC6D8E-6352-4153-AD7B-3470733F6E5C Q37714724-AEBEE4A8-78C9-43B6-A7B0-5EE0D6DAD1C2 Q37731385-7B0922F2-8444-4D12-A1A4-738A0AA8EAE9 Q39129323-E56F0E87-7C5A-4A00-AAC3-B6C63460AC47 Q39205050-CF539449-1AD8-426A-B235-2827DD9E32B7 Q39367102-718B5D2A-181C-4760-811A-D7CE46BD10E0 Q47215993-FF23F5D5-33DA-4E05-859F-443F2DC677CF Q49178138-EAE89615-65C0-4075-8BB2-C52B1B81CBDA Q51066789-31AE9CED-FDA9-4A16-B3AA-A8F19108EECB Q55140242-2857EB46-A66B-4284-8C1C-062D983630BB Q57124811-41838607-C2CE-4618-B3F1-63108DE0B2DE

P2860

Muscle-derived follistatin-like 1 functions to reduce neointimal formation after vascular injury

http://www.wikidata.org/entity/Q28238431

description

2014 nî lūn-bûn

@nan

2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Muscle-derived follistatin-lik ...... ormation after vascular injury

@ast

Muscle-derived follistatin-lik ...... ormation after vascular injury

@en

Muscle-derived follistatin-lik ...... ormation after vascular injury

@nl

type

label

Muscle-derived follistatin-lik ...... ormation after vascular injury

@ast

Muscle-derived follistatin-lik ...... ormation after vascular injury

@en

Muscle-derived follistatin-lik ...... ormation after vascular injury

@nl

prefLabel

Muscle-derived follistatin-lik ...... ormation after vascular injury

@ast

Muscle-derived follistatin-lik ...... ormation after vascular injury

@en

Muscle-derived follistatin-lik ...... ormation after vascular injury

@nl

P1433

Q28238431-C5597DCA-DAFF-4E0E-8968-48CDE30A576D

P1476

Q28238431-6E80AEA2-96A1-47BC-86C9-6D2046C3050C

P2093

Q28238431-38904ECD-DD70-49D6-9887-C307943589B8

Q28238431-49825065-84C0-4BB7-BB94-A89D9BCCC87A

Q28238431-56C8503F-F2EA-4CF3-B0E6-AED69F5B051B

Q28238431-59E42676-12CA-45AA-B81C-1D9B17849D1F

Q28238431-60971E77-CB31-41DA-985C-B29F17B93BF1

Q28238431-6D63AC1D-E329-43B3-B860-EF47F7FEC0B2

Q28238431-7B34AADD-B7C6-4284-B577-0055EFDFB2A4

Q28238431-89DE4FDB-AED0-4E58-A00D-2A69F66FD6EF

Q28238431-931AA041-F2CC-4CBD-A700-4DB698F9FB3E

Q28238431-96DF756E-E57C-4164-8E08-375753301B96

P2860

Q28238431-1532135F-645C-4CED-859D-4C6E039ADEC5

Q28238431-18BAFBF2-D854-432B-8E55-DFFD4A4C34BC

Q28238431-1906BE30-5A9F-4E55-AEA7-C129DFCE8E94

Q28238431-1BCE0B34-3952-47DE-8DEB-E82E62AA9B2F

Q28238431-1CF0E569-F839-44B2-B50F-CB7A17145A4E

Q28238431-23F1755D-509B-4643-BFDB-98B0B42926DC

Q28238431-3E4F8D2E-4EC6-4192-8D40-9D34CE8C50BA

Q28238431-3FA100FB-D14B-4E90-8AC2-E517098BCEFC

Q28238431-4D0CB5EA-E2EB-4C5E-942E-A54FFE5A156E

Q28238431-53C13D4B-0805-4D79-9C46-521EA5FF7F18

P304

Q28238431-FED8EEEC-15B4-490B-8608-52F7641FF134

P31

Q28238431-765C275C-0C12-4E08-BAF9-1E9F9B62664F

P3181

Q28238431-2D3F164D-275D-452E-9297-69C5DAE308D0

P356

Q28238431-9D42DC84-FFBD-4D6F-B7C2-124BB5EBC223

P407

Q28238431-BA4EDB05-7538-47CD-A581-FDAFCF3FA2DF

P433

Q28238431-06FEB78F-665D-4097-973A-E3DAD8880162

P478

Q28238431-530F1743-F5FF-47BE-AC44-C1DD6C559086

P577

Q28238431-942ACB38-8B26-49E0-B96B-76ADF04A3996

P5875

Q28238431-834C078B-F20C-4970-8418-A9F7B521010D

P698

Q28238431-72CA8284-D3D2-4D3F-A2D1-8D6E93030637

P932

Q28238431-D6E81DA4-46DA-48B6-8D68-3AF696EF9369

P3181

P356

P1433

Cardiovascular Research

P1476

Muscle-derived follistatin-lik ...... ormation after vascular injury

@en

P2093

Daisuke Yuasa

http://www.w3.org/2001/XMLSchema#string

Kazuhiro Matsuo

http://www.w3.org/2001/XMLSchema#string

Kenneth Walsh

http://www.w3.org/2001/XMLSchema#string

Koji Ohashi

http://www.w3.org/2001/XMLSchema#string

Masanori Ito

http://www.w3.org/2001/XMLSchema#string

Maurice J B Van Den Hoff

http://www.w3.org/2001/XMLSchema#string

Megumi Miyabe

http://www.w3.org/2001/XMLSchema#string

Mizuho Hiramatsu-Ito

http://www.w3.org/2001/XMLSchema#string

Noriyuki Ouchi

http://www.w3.org/2001/XMLSchema#string

Rei Shibata

http://www.w3.org/2001/XMLSchema#string

P2860

The BMP antagonist follistatin-like 1 is required for skeletal and lung organogenesis

Mechanisms, Pathophysiology, and Therapy of Arterial Stiffness

DIP2A functions as a FSTL1 receptor

BetaKlotho is required for metabolic activity of fibroblast growth factor 21

Cardiac myocyte follistatin-like 1 functions to attenuate hypertrophy following pressure overload

Therapeutic impact of follistatin-like 1 on myocardial ischemic injury in preclinical models

A PGC1-α-dependent myokine that drives brown-fat-like development of white fat and thermogenesis

Heart disease and stroke statistics--2011 update: a report from the American Heart Association

Role of smooth muscle cells in the initiation and early progression of atherosclerosis.

Progressive resistance exercise and resting blood pressure : A meta-analysis of randomized controlled trials.

P304

111-20

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1355769

http://www.w3.org/2001/XMLSchema#string

P356

10.1093/CVR/CVU105

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

103

http://www.w3.org/2001/XMLSchema#string

P577

2014-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

261757392

http://www.w3.org/2001/XMLSchema#string

P698

24743592

http://www.w3.org/2001/XMLSchema#string

P932

4834864

http://www.w3.org/2001/XMLSchema#string